Advances in Drug Discovery. From Human Genetic Signatures to Drug Targets
Johnson & Johnson
5 de mayo 2021
The Johnson & Johnson Innovation team is hosting Advances in Drug Discovery: From Human Genetic Signatures to Drug Targets, a scientific and virtual partnering event taking place on 5 May. We have over 500 participants already registered from across the discovery sciences, translational and genomics emerging innovation space from Europe, North America, and beyond.
More information in the event page